文献速递骨科与运动康复疼痛康复

透明质酸与皮质类固醇、富血小板血浆及物理治疗在慢性肩痛中的疗效比较:系统评价与频率学派网状Meta分析

Comparison of the Efficacy of Hyaluronic Acid Versus Corticosteroids, Platelet-Rich Plasma, and Physical Therapy in Chronic Shoulder Pain: A Systematic Review and a Frequentist Network Meta-Analysis.
PubMed 文献 · Arch Phys Med Rehabil · 2026-04-30

结果显示,在肌腱病变中物理治疗在3个月和6个月时对静息痛、夜间痛和活动痛的缓解均优于透明质酸;透明质酸可能有助于改善生活质量和特定关节活动度参数。

要点

  • 在肩肌腱病变中,物理治疗对静息痛、夜间痛和活动痛的缓解在3个月和6个月时均优于低分子量和高分子量透明质酸。
  • 透明质酸可能改善生活质量和特定关节活动度参数,高分子量透明质酸在粘连性关节囊炎中显示中等疗效。
  • 不同肩部疾病中,高分子量透明质酸与低分子量透明质酸在疼痛结局上无差异。

核心结论

  • 在肩肌腱病变中,物理治疗在3个月和6个月时对静息痛、夜间痛和活动痛的缓解均优于透明质酸制剂。
  • 透明质酸可能有助于改善生活质量和特定关节活动度参数,但需进一步高质量研究巩固这些发现。

主要发现

  • 在肌腱病变中,物理治疗较高分子量透明质酸降低静息痛(3个月MD=-3.02,P<.01;6个月MD=-2.08,P<.01),较地分子量透明质酸降低静息痛(6个月MD=-1.95,P<.01)。
  • 在肌腱病变中,物理治疗在6个月时对夜间痛和活动痛的缓解均优于两种透明质酸制剂。
  • 考虑不同肩部疾病时,高分子量透明质酸与低分子量透明质酸在疼痛结局上无差异。
  • 透明质酸在3个月时改善不同肩部疾病的内收和内旋;在肌腱病变中物理治疗在6个月时对屈曲和外旋更优。
  • 按病理分层,高分子量透明质酸在粘连性关节囊炎中显示中等疗效;高分子量透明质酸在3个月时较地分子量透明质酸改善功能状态;皮质类固醇改善不同原因肩部疾病的外展。

关键数值与推荐

  • 疼痛结局采用均数差(MD)和标准化均数差(SMD),P<.05为统计学显著。
  • 在肌腱病变中,物理治疗vs高分子量透明质酸静息痛3个月MD=-3.02(P<.01)、6个月MD=-2.08(P<.01);vs低分子量透明质酸6个月MD=-1.95(P<.01)。

临床怎么用

  • 对慢性肩痛肌腱病变患者,物理治疗可作为优先考虑以更好控制静息痛、夜间痛和活动痛。
  • 透明质酸注射可能作为改善生活质量和特定关节活动度参数的辅助选择,尤其高分子量透明质酸在粘连性关节囊炎中显示中等疗效。
  • 皮质类固醇可用于改善不同原因肩部疾病的外展活动度。

局限性

  • 需要进一步高质量研究来巩固这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the effectiveness of injected low- and high-molecular-weight hyaluronic acid (HA-LMW, HA-HMW) versus corticosteroids (CCS), placebo-or physical therapy (PT), on pain at rest (Prest), at night (Pnight), and during activity (Pact), range of motion (ROM), functional status (FS), and quality of life in patients with chronic shoulder pain (Sp) at 3 and 6 months follow-up. DATA SOURCES: A systematic literature search was conducted through October 2024 across MEDLINE, Embase, and Cochrane CENTRAL. STUDY SELECTION: Fourteen studies were included: 12 randomized controlled trials and 2 prospective cohort studies that compared at least 2 of the treatments of interest in adults with chronic Sp. DATA EXTRACTION: Two reviewers independently extracted data related to the outcomes. DATA SYNTHESIS: A frequentist network meta-analysis with mean differences (MDs) and standardized mean differences (SMD) was performed; P<.05 was statistically significant. PT reduced Prest compared to HA-HMW (MD = -3.02, P<.01 at 3 mo; MD = -2.08, P<.01 at 6 mo) and HA-LMW (MD = -1.95, P<.01 at 6 mo) in tendinopathy. PT showed greater reduction than both HA formulations in Pnight and Pact at 6 months in tendinopathy. No differences were observed between HA-HMW and HA-LMW for pain outcomes considering shoulder different diseases. HA improved adduction and internal rotation at 3 months considering shoulder different disease; PT was superior for flexion and external rotation at 6 months in tendinopathy. Stratified by pathology, HA-HMW showed moderate efficacy in adhesive capsulitis. HA-HMW improved FS compared to HA-LMW at 3 months. CCS improved abduction in shoulder disease due to different causes. CONCLUSIONS: PT provides greater pain control for Sptendinopathy, particularly for Prest, Pnight, and Pact at both 3 and 6 months. HA may contribute to improved quality of life and specific ROM parameters. Further high-quality studies are required to consolidate these findings.

来源:Arch Phys Med Rehabil,查看原文。版权归原作者所有。

引用

  1. Marra A, de Siena AU, Iacovazzo C, et al. Comparison of the Efficacy of Hyaluronic Acid Versus Corticosteroids, Platelet-Rich Plasma, and Physical Therapy in Chronic Shoulder Pain: A Systematic Review and a Frequentist Network Meta-Analysis. Arch Phys Med Rehabil. 2026. PMID: 42069289. doi:10.1016/j.apmr.2026.04.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。